{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:04:52Z","timestamp":1789193092254,"version":"build-2803163510"},"reference-count":57,"publisher":"Massachusetts Medical Society","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2018,10,4]]},"DOI":"10.1056\/nejmcp1702493","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T17:03:10Z","timestamp":1538586190000},"page":"1343-1352","source":"Crossref","is-referenced-by-count":201,"title":["Acne Vulgaris"],"prefix":"10.1056","volume":"379","author":[{"given":"Andrea L.","family":"Zaenglein","sequence":"first","affiliation":[{"name":"From the Departments of Dermatology and Pediatrics, Penn State Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.2147\/AHMT.S55832"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.06.045"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.446"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/1751-0759-5-11"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02768.x"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13786"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb05757.x"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04444.x"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb02433.x"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.15171\/hpp.2017.19"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2006.00276.x"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.12.037"},{"key":"e_1_3_4_14_2","first-page":"111","article-title":"Simplifying the language of evidence to improve patient care: Strength of Recommendation Taxonomy (SORT): a patient-centered approach to grading evidence in medical literature.","volume":"53","author":"Ebell MH","year":"2004","unstructured":"Ebell MH, Siwek J, Weiss BD, et al. Simplifying the language of evidence to improve patient care: Strength of Recommendation Taxonomy (SORT): a patient-centered approach to grading evidence in medical literature. J Fam Pract 2004;53:111-120.14764293","journal-title":"J Fam Pract"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.02.031"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70141-0"},{"key":"e_1_3_4_17_2","first-page":"773","article-title":"An ultrastructural study of the effects of topical tretinoin on microcomedones.","volume":"14","author":"Lavker RM","year":"1992","unstructured":"Lavker RM, Leyden JJ, Thorne EG. An ultrastructural study of the effects of topical tretinoin on microcomedones. Clin Ther 1992;14:773-780.1283729","journal-title":"Clin Ther"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1365-2133.1998.1390s2026.x","article-title":"Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life.","volume":"139","author":"Grosshans E","year":"1998","unstructured":"Grosshans E, Marks R, Mascaro JM, et al. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol 1998;139:Suppl 52:26-33.9990418","journal-title":"Br J Dermatol"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.10.879"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0178-4"},{"key":"e_1_3_4_21_2","first-page":"12","article-title":"Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.","volume":"69","author":"Leyden JJ","year":"2002","unstructured":"Leyden JJ, Tanghetti EA, Miller B, Ung M, Berson D, Lee J. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial. Cutis 2002;69:Suppl:12-19.12095064","journal-title":"Cutis"},{"key":"e_1_3_4_22_2","first-page":"4","article-title":"A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.","volume":"69","author":"Webster GF","year":"2002","unstructured":"Webster GF, Guenther L, Poulin YP, Solomon BA, Loven K, Lee J. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris. Cutis 2002;69:Suppl:4-11.12095066","journal-title":"Cutis"},{"key":"e_1_3_4_23_2","first-page":"417","article-title":"Antibiotic-resistant propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.","volume":"82","author":"Leyden JJ","year":"2008","unstructured":"Leyden JJ, Wortzman M, Baldwin EK. Antibiotic-resistant propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%. Cutis 2008;82:417-421.19181031","journal-title":"Cutis"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2011.641937"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.04.1110"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70177-4"},{"key":"e_1_3_4_27_2","first-page":"31","article-title":"Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris.","volume":"8","author":"Del Rosso JQ","year":"2015","unstructured":"Del Rosso JQ, Kircik L, Gallagher CJ. Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris. J Clin Aesthet Dermatol 2015;8:31-37.25610522","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_4_28_2","first-page":"197","article-title":"The efficacy and safety of topical dapsone gel, 5% for the treatment of acne vulgaris in adult females with skin of color.","volume":"15","author":"Alexis AF","year":"2016","unstructured":"Alexis AF, Burgess C, Callender VD, et al. The efficacy and safety of topical dapsone gel, 5% for the treatment of acne vulgaris in adult females with skin of color. J Drugs Dermatol 2016;15:197-204.26885788","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_4_29_2","first-page":"15","article-title":"Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women.","volume":"12","author":"Lynde CW","year":"2014","unstructured":"Lynde CW, Andriessen A. Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women. Skinmed 2014;12:15-21.24720080","journal-title":"Skinmed"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2008.518"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3186"},{"key":"e_1_3_4_32_2","first-page":"94","article-title":"Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.","volume":"85","author":"Gold LS","year":"2010","unstructured":"Gold LS, Cruz A, Eichenfield L, et al. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg. Cutis 2010;85:94-104.20349684","journal-title":"Cutis"},{"key":"e_1_3_4_33_2","first-page":"619","article-title":"A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic\/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.","volume":"12","author":"Zaenglein AL","year":"2013","unstructured":"Zaenglein AL, Shamban A, Webster G, et al. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic\/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris. J Drugs Dermatol 2013;12:619-625.23839176","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.5.597"},{"key":"e_1_3_4_35_2","first-page":"581","article-title":"Efficacy and safety of subantimicrobial dose, modified-release doxycycline 40 mg versus doxycycline 100 mg versus placebo for the treatment of inflammatory lesions in moderate and severe acne: a randomized, double-blinded, controlled study.","volume":"14","author":"Moore A","year":"2015","unstructured":"Moore A, Ling M, Bucko A, Manna V, Rueda MJ. Efficacy and safety of subantimicrobial dose, modified-release doxycycline 40 mg versus doxycycline 100 mg versus placebo for the treatment of inflammatory lesions in moderate and severe acne: a randomized, double-blinded, controlled study. J Drugs Dermatol 2015;14:581-586.26091383","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.03.051"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2016.12.002"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb05722.x"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2017.3062"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1159\/000471799"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.34"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.8.1016"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.03.019"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12079"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2010.00657.x"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5812"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.264"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1638"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.164358"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jand.2017.03.024"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12673"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1346"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/86.1.107"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.04.030"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13835"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2022"},{"key":"e_1_3_4_57_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","article-title":"European evidence-based (S3) guidelines for the treatment of acne.","volume":"26","author":"Nast A","year":"2012","unstructured":"Nast A, Dr\u00e9no B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012;26:Suppl 1:1-29.22356611","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15843"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMcp1702493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:34:48Z","timestamp":1711485288000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMcp1702493"}},"subtitle":[],"editor":[{"given":"Caren G.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":57,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018,10,4]]}},"alternative-id":["10.1056\/NEJMcp1702493"],"URL":"https:\/\/doi.org\/10.1056\/nejmcp1702493","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,4]]}}}